NATCO 30 (Lansoprazole delayed-release 30 mg)
Pill imprint NATCO 30 has been identified as Lansoprazole delayed-release 30 mg.
Lansoprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; zollinger-ellison syndrome; helicobacter pylori infection (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for NATCO 30 (Lansoprazole delayed-release 30 mg)
Lansoprazole delayed-release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...